Pharmacoepidemiology of insulin initiation in diabetes care

Pogach, Leonard

doi:10.1503/cmaj.090841

Cited by 2 publications

(1 citation statement)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This treatment is invasive and painful, and frequently negatively affects the patient--physician relationship and, consequently, the physician is reluctant to start it. Other concerns are also involved, since physicians, patients and families worry about the side effects, such hypoglycemia and weight gain, specially in elderly patients (13,(28)(29)(30).…”

Section: Discussionmentioning

confidence: 99%

Prescription patterns for diabetes mellitus and therapeutic implications: a population-based analysis

Guidoni

Borges

Freitas

et al. 2012

Arq Bras Endocrinol Metab

View full text Add to dashboard Cite

Objective: To analyze drug prescriptions for insulin and oral antidiabetic drugs in type 1 and type 2 diabetes mellitus patients seen in the Brazilian Public Healthcare System (Unified Health System -SUS) in Ribeirao Preto, SP, Brazil. Subjects and methods: All the patients with diabetes seen in the SUS in the western district of Ribeirao Preto, SP, Brazil between March/2006 and February/2007 were included in the study. Results: A total of 3,982 patients were identified. Mean age of the patients was 60.6 years, and 61.0% were females. Sixty percent of the patients were treated with monotherapy. Doses of oral antidiabetic drugs were lower in monotherapy than in polytherapy. Ten patients received doses of glibenclamide or metformin above the recommended maximum doses, and in elderly patients there was no reduction in drug doses. Conclusion: Monotherapy with oral antidiabetic drugs was the predominant procedure, and the doses were not individualized according to age.

show abstract

Section: Discussionmentioning

confidence: 99%

Prescription patterns for diabetes mellitus and therapeutic implications: a population-based analysis

Guidoni

Borges

Freitas

et al. 2012

Arq Bras Endocrinol Metab

View full text Add to dashboard Cite

show abstract

Current awareness: Pharmacoepidemiology and drug safety

2009

Pharmacoepidemiology and Drug

View full text Add to dashboard Cite

In order to keep subscribers up‐to‐date with the latest developments in their field, John Wiley & Sons are providing a current awareness service in each issue of the journal. The bibliography contains newly published material in the field of pharmacoepidemiology and drug safety. Each bibliography is divided into 23 sections: 1 Reviews; 2 General; 3 Anti‐infective Agents; 4 Cardiovascular System Agents; 5 CNS Depressive Agents; 6 Non‐steroidal Anti‐inflammatory Agents; 7 CNS Agents; 8 Anti‐neoplastic Agents; 9 Haematological Agents; 10 Neuroregulator‐Blocking Agents; 11 Dermatological Agents; 12 Immunosuppressive Agents; 13 Autonomic Agents; 14 Respiratory System Agents; 15 Neuromuscular Agents; 16 Reproductive System Agents; 17 Gastrointestinal System Agents; 18 Anti‐inflammatory Agents ‐ Steroidal; 19 Teratogens/fetal exposure; 20 Antidiabetic Agents; 21 Contrast Agents; 22 Bone Conservation Agents; 23 Others. Within each section, articles are listed in alphabetical order with respect to author. If, in the preceding period, no publications are located relevant to any one of these headings, that section will be omitted.

show abstract

Pharmacoepidemiology of insulin initiation in diabetes care

Cited by 2 publications

References 11 publications

Prescription patterns for diabetes mellitus and therapeutic implications: a population-based analysis

Prescription patterns for diabetes mellitus and therapeutic implications: a population-based analysis

Current awareness: Pharmacoepidemiology and drug safety

Contact Info

Product

Resources

About